Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.31 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
| ▸ | HTR1D | P28221 | 1/20 | 0.30 |
| ▸ | HTR1B | P28222 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18094450 | 0.86 | TSHR (0.41) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 | |
| SCHEMBL1753908 | 0.83 | ERBB2 (0.34) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 | |
| SCHEMBL3286259 | 0.79 | ALDH1A1 (0.35) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 | |
| SCHEMBL15935509 | 0.78 | KLF10 (0.33) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 | |
| SCHEMBL31107047 | 0.78 | GABRA1 (0.33) | ALDH1A1HPGDHSD17B10TDP1GABRA1 | |
| SCHEMBL4141419 | 0.78 | ALDH1A1 (0.59) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 | |
| SCHEMBL21125905 | 0.75 | CA2 (0.41) | ALDH1A1HPGDHSD17B10TDP1POLB | |
| SCHEMBL6354584 | 0.74 | GABRA1 (0.43) | ALDH1A1CYP3A4HPGDTSHRHSD17B10 | |
| SCHEMBL16011392 | 0.73 | — | — | |
| SCHEMBL7525355 | 0.72 | ALDH1A1 (0.42) | ALDH1A1HPGDTSHRHSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7981525-B2 | Naphthalene compound and organic light-emitting device using the compound | CANON KABUSHIKI KAISHA (JP) | 2011-07-19 | — | — | US | disclosed |
| US-7981525-B2 | Naphthalene compound and organic light-emitting device using the compound | CANON KABUSHIKI KAISHA (JP) | 2011-07-19 | — | — | US | disclosed |
| US-20080224603-A1 | NAPHTHALENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2008-09-18 | — | — | US | disclosed |
| US-20080224603-A1 | NAPHTHALENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2008-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080224603-A1 | NAPHTHALENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE COMPOUND | AHR, CRY1, NR2E3 | ALDH1A1 40/4885CYP3A4 172/4885HPGD 1730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.